Welcome to NHLBI-PEN Project
—
filed under:
Executive Committee Meeting
Integrated Nanosystems for Diagnosis and Therapy - Program of Excellence in Nanotechnology The central mission of this project (Project Number: HL080729) is to develop a group of well-characterized and versatile nanoscale agents that can be assembled, labeled, targeted, filled, and activated as needed for the diagnosis and treatment of various diseases of relevance to the National Heart Lung and Blood Institute (NHLBI). The overall experimental strategy is focus on biological models of acute pulmonary and systemic vascular injury (in vitro and in vivo) to demonstrate the effectiveness of these agents. Acute vascular injury and inflammation have been chosen as general targets since they affect tissues broadly, including those of the lung and cardiovascular system.
For more information about the NHLBI-PEN Project please contact:
Document Actions |
|
